Health Care & Life Sciences » Biotechnology | ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. | Ownership

Companies that own ACADIA Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Baker Bros. Advisors LP
27,228,338
21.78%
0
2.52%
06/30/2018
Fidelity Management & Research Co.
18,710,395
14.97%
18,604
0.03%
06/30/2018
The Vanguard Group, Inc.
8,463,407
6.77%
364,321
0%
06/30/2018
BlackRock Fund Advisors
7,642,088
6.11%
2,296,880
0.01%
06/30/2018
SSgA Funds Management, Inc.
5,826,875
4.66%
1,651,126
0.01%
06/30/2018
OppenheimerFunds, Inc.
4,458,376
3.57%
112,430
0.04%
06/30/2018
OrbiMed Advisors LLC
4,282,400
3.43%
941,700
0.64%
06/30/2018
Henderson Global Investors Ltd.
3,448,610
2.76%
-3,546,991
0.02%
06/30/2018
Point72 Asset Management LP
3,094,501
2.48%
-1,262,925
0.22%
06/30/2018
First Trust Advisors LP
2,603,446
2.08%
840,425
0.07%
06/30/2018

About ACADIA Pharmaceuticals

View Profile
Address
3611 Valley Centre Drive
San Diego California 92130
United States
Employees -
Website http://www.acadia-pharm.com
Updated 07/08/2019
ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. It operates through development and commercialization of innovative medicines segment. The company was founded by Mark R.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.